Dems want to unmask Eli Lilly's obesity drug user, a new genome-editing tool raises ethics questions, and more health news
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: Embryo editing advances reignite ethical debates | 0 | 5 | 26-06-2026 |
| 2 | Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkiller | 0 | 7 | 25-06-2026 |
| 3 | STAT+: Democrats press White House on who got special access to Eli Lilly’s new obesity drug | 0 | 7 | 25-06-2026 |
| 4 | The mysterious case of Eli Lilly’s obesity drug | 0 | 5 | 25-06-2026 |
| 5 | STAT+: Next-gen CRISPR tools improve editing accuracy in embryos, but also stoke ethical concerns | 0 | 7 | 25-06-2026 |
| 6 | Conn. Provider Must Share Takeover Data After $49M Verdict | 0 | 7 | 26-06-2026 |
| 7 | Opinion: Supreme Court ruling on Roundup points to a confusing difference between the law and science | 0 | 5 | 27-06-2026 |
| 8 | Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days | 0 | 5 | 31-07-2025 |
| 9 | STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better | 0 | 7 | 25-06-2026 |
| 10 | What is pulmonary hypertension and why would a new GLP-1 help? | 0 | 5 | 26-06-2026 |